Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Environ Toxicol Chem ; 34(5): 1185-95, 2015 May.
Article in English | MEDLINE | ID: mdl-25655985

ABSTRACT

The normal range has been defined as the range that encloses 95% of reference values; in practice this range has been defined as the reference mean ± 2 standard deviations (SD). When sample sizes are small and reference data are not normally distributed, the mean ± 2 SDs do not enclose 95% of data values. Prediction intervals (PI) calculated using sample statistics are used in the present study to define the normal range for a single observation and the mean of m observations. The PIs provide confidence limits for the next randomly selected observation (or mean of m observations) from a population. The PIs are defined using normally distributed reference data; normality can typically be achieved with transformations of the data. Covariates can be used to explain some of the variability in the reference distribution, increasing the ability to detect change. When assumptions of normality are not met, alternative methods of defining the normal range are provided. The normal range can be used to quantify natural variability and assess change from the reference distribution. It can be used as an early warning indicator of change in environmental monitoring to identify the need for further investigation.


Subject(s)
Environmental Monitoring , Analysis of Variance , Animals , Biomass , Copper/analysis , Fishes/metabolism , Lakes/chemistry , Mining , Models, Biological , Models, Statistical , Muscles/chemistry , Muscles/metabolism , Plankton/drug effects , Reference Values , Water Pollutants, Chemical/toxicity
3.
Environ Toxicol Chem ; 29(9): 1957-66, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20821653

ABSTRACT

Perfluorooctane sulfonate (PFOS; C(8)F(17)SO(3) (-)) bioaccumulation and toxicity have been demonstrated in both aquatic and terrestrial organisms. The majority of investigations have examined total PFOS concentrations in wildlife and in toxicity testing, but isomer-specific monitoring studies are less common, and no laboratory-based study of PFOS isomer accumulation in fish has been reported. The present study examined accumulation and maternal transfer of PFOS isomers in zebrafish and tissue-specific accumulation of PFOS isomers in trout parr. A median lethal dose (LC50) of 22.2 and 2.5 mg/L was calculated for adult zebrafish and trout parr, respectively. A two-week PFOS exposure resulted in tissue-specific PFOS accumulation in trout, with maximum concentrations identified in the liver tissue (>50 microg/g). Prior exposure to PFOS as alevin did not affect the accumulation of PFOS in tissues later in life. In both species, accumulation of branched PFOS isomers generally occurred to a lesser extent than linear PFOS, which may explain the relative deficiency of branched PFOS isomers in some aquatic species in the field. Analysis of exposed trout tissues indicated that isomer discrimination may occur at the level of elimination or uptake and elimination processes in the kidney or gill, respectively. When zebrafish underwent a reproductive cycle in the presence of PFOS, approximately 10% (wt) of the adult PFOS body burden was transferred to the developing embryos, resulting in a higher total PFOS concentration in eggs (116 +/- 13.3 microg/g) than in the parent fish (72.1 +/- 7.6 microg/g). The isomer profile in eggs was not significantly different from that of adults, suggesting that the maternal transfer of branched and linear PFOS isomers in fish is largely nonisomer specific.


Subject(s)
Alkanesulfonic Acids/metabolism , Fluorocarbons/metabolism , Oncorhynchus mykiss/metabolism , Water Pollutants, Chemical/metabolism , Zebrafish/metabolism , Alkanesulfonic Acids/toxicity , Animals , Environmental Monitoring , Female , Fertility/drug effects , Fluorocarbons/toxicity , Isomerism , Maternal Exposure , Ovum/metabolism , Water Pollutants, Chemical/toxicity
4.
Comp Biochem Physiol C Toxicol Pharmacol ; 145(4): 507-17, 2007 May.
Article in English | MEDLINE | ID: mdl-17428736

ABSTRACT

The potential for contaminants to alter lipid or cholesterol dynamics in fish is rarely investigated and may include critical physiological endpoints that are impacted by exposure to endocrine-active substances. The current study investigated plasma and tissue lipid dynamics over a period of recrudescence in goldfish, while also examining the potential for beta-sitosterol (beta-sit), a phytosterol and 17beta-estradiol (E(2)), an endogenous estrogen, to alter lipid homeostasis. Goldfish were exposed to 0 microg/g (no chemical; control), 200 microg/g beta-sit (72.3% sitosterol mixture) or 10 microg/g 17beta-estradiol (E2) via Silastic implants for a period of five months. Plasma lipids peaked in control fish coincident with maximum liver size, while gonadal cholesterol concentration was highest concomitant with maximum gonad size. Plasma lipid concentrations were highly affected by E2 but not beta-sit exposure; E2 elevated total cholesterol (p<0.001) and triglyceride (TG; p<0.001) and decreased high-density lipoprotein (HDL) concentration (p<0.001) in male fish. Tissue cholesterol concentrations were minimally affected by beta-sit exposure, while hepatic cholesterol concentrations were increased in E2 exposed females (p=0.041), indicating elevated liver lipogenesis in response to E2, but not beta-sit, exposure. The present study demonstrates differential effects by beta-sit and E2 on plasma lipoprotein profile and TG concentration and indicates estrogen-specific effects on hepatic lipid metabolism during gonadal development.


Subject(s)
Cholesterol/metabolism , Estradiol/pharmacology , Gonads/growth & development , Lipids/blood , Sitosterols/pharmacology , Animals , Female , Goldfish , Liver/metabolism , Male , Testosterone/blood , Triglycerides/blood
5.
Gen Comp Endocrinol ; 151(1): 34-41, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17196966

ABSTRACT

Fish exposed to the phytosterol beta-sitosterol (beta-sit) have decreased circulating hormone and cholesterol concentrations, and decreased gonadal intra-mitochondrial cholesterol pools. The current study examined the potential for beta-sit to alter abundance of the key cholesterol transport protein, steroidogenic acute regulatory (StAR) protein, which delivers cholesterol to the first and rate-limiting steroidogenic enzyme P450 side chain cleavage (P450(scc)) inside the mitochondria. Plasma testosterone (T) and lipids (cholesterol, lipoproteins and triglycerides) were also measured. Goldfish were exposed to 200 microg/g beta-sit (97% pure or as a 72.6% pure phytosterol mixture) and 10 microg/g 17beta-estradiol (E(2); estrogenic control) by intra-peritoneal Silastic implants for 21-days or for five-months. Plasma T was significantly decreased in male fish exposed to the phytosterol mixture following the long-term exposure (p<0.001). There were no differences in total cholesterol concentrations among treatments in the short- or long-term exposure, but male fish in the long-term exposure had significantly lower HDL as compared to control fish (p<0.025) with a corresponding increase in LDL. StAR transcript levels were unchanged following the short-term exposure, but were reduced after five months in male beta-sit fish (p=0.05) and E(2)-treated female fish (p=0.05). This reduction in StAR transcript abundance in conjunction with decreased plasma T and altered plasma lipoprotein fractions demonstrates a non-estrogenic effect of beta-sit. This is the first study to show that beta-sit has the capacity to alter gonadal StAR transcript abundance, offering a mechanism by which beta-sit disrupts reproductive endocrine endpoints.


Subject(s)
Estradiol/pharmacology , Goldfish/metabolism , Gonads/metabolism , Phosphoproteins/metabolism , Sitosterols/pharmacology , Animals , Cholesterol/blood , Estradiol/chemistry , Female , Goldfish/genetics , Gonads/drug effects , Lipids/blood , Male , Molecular Structure , Phosphoproteins/genetics , Radioimmunoassay , Reverse Transcriptase Polymerase Chain Reaction , Sitosterols/chemistry , Testosterone/blood , Transcription, Genetic/drug effects
6.
Reprod Biol Endocrinol ; 4: 60, 2006 Nov 21.
Article in English | MEDLINE | ID: mdl-17118198

ABSTRACT

Total and intra-mitochondrial gonadal cholesterol concentrations are decreased in fish exposed to the phytoestrogen beta-sitosterol (beta-sit). The present study examined the potential for beta-sit to disrupt de novo cholesterol synthesis in the gonads of goldfish exposed to 200 microgram/g beta-sit and 10 microgram/g 17beta-estradiol (E2; estrogenic control) by intra-peritoneal Silastic implants for 21 days. The de novo cholesterol synthetic capacity was estimated by incubating gonadal tissue with 14C-acetate for a period of 18 hours, followed by chloroform/methanol lipid extraction and thin layer chromatography (TLC) lipid separation. Lipid classes were confirmed using infrared spectroscopy. Plasma testosterone (T) and total cholesterol concentration were measured and gonadosomatic index (GSI) was calculated. Plasma T was significantly reduced in male beta-sit-treated fish compared to control and E2-treated fish (p < 0.001). 14C-Acetate incorporation into cholesterol and cholesterol esters was not significantly different among treatment groups for male and female fish, however, 14C-enrichment was higher than expected in both triglycerides (TG) and free fatty acids (FFA). FFA incorporation was significantly higher in male control fish than either beta-sit or E2 treatments (p = 0.005). Plasma cholesterol concentration was significantly increased in the male beta-sit treatment group compared to controls (p = 0.027). These results indicate gonadal de novo cholesterol biosynthetic capacity is not disrupted by beta-sit or E2 treatment in early recrudescing male or female goldfish, while plasma cholesterol and steroid concentrations are sensitive to beta-sit exposure.


Subject(s)
Cholesterol/biosynthesis , Goldfish/metabolism , Hypolipidemic Agents/pharmacology , Ovary/metabolism , Sitosterols/pharmacology , Testis/metabolism , Animals , Cholesterol/blood , Drug Implants , Female , Hypolipidemic Agents/administration & dosage , Male , Organ Size , Ovary/anatomy & histology , Ovary/drug effects , Sex Factors , Sitosterols/administration & dosage , Testis/anatomy & histology , Testis/drug effects , Testosterone/blood
7.
Aquat Toxicol ; 67(3): 203-15, 2004 Apr 28.
Article in English | MEDLINE | ID: mdl-15063071

ABSTRACT

A short-term gonadal recrudescence bioassay using the mummichog (Fundulus heteroclitus) was employed to examine the consequences of environmentally relevant and pharmacological exposures (1-1000 ng/l) of the androgen, 17alpha-methyl testosterone (MT), and the anti-androgen, cyproterone acetate (CA), on reproductive endocrine endpoints. Recrudescing male (GSI = approx. 2%) and female (GSI = approx. 10%) fish were exposed to graded concentrations of MT and CA for 7 or 14 days. In the first experiment (7-day exposure), MT concentrations of 250 or 1000 ng/l decreased circulating testosterone (T) and estradiol (E(2)) in female fish, and 11-ketotestosterone (11-KT) in male fish. Plasma T, 11-KT and E(2) were decreased following CA exposure (250 and 1000 ng/l). Gonadal steroid biosynthetic capacity was also inhibited in both sexes after exposure to MT or CA, as evidenced by decreased in vitro production of T and E(2). In experiment 2 (14-day exposure), exposures to lower MT and CA concentrations (1, 10 and 100 ng/l) resulted in decreased plasma T, with females showing greater sensitivity than males. Both 11-KT and E(2) were significantly reduced beginning at 10 ng/l MT. In vitro gonadal T production was impaired at 100 ng/l MT in both males and females while 1 ng/l CA caused a significant decrease in female fish. In experiment 2, in vitro E(2) production was decreased in females at all concentrations of MT and CA, while only 100 ng/l reduced 11-KT synthesis in males. Plasma vitellogenin (Vtg) was reduced in females exposed to 1000 ng/l (experiment 1) and 100 ng/l (experiment 2) MT, while CA did not alter plasma Vtg at any concentration. This bioassay has the potential to be used to assess the possible consequences in estuarine fish of exposure to environmental anti/androgens.


Subject(s)
Androgen Antagonists/pharmacology , Cyproterone Acetate/pharmacology , Fundulidae/metabolism , Gonads/drug effects , Methyltestosterone/pharmacology , Testosterone/analogs & derivatives , Animals , Biological Assay , Estradiol/biosynthesis , Estradiol/blood , Female , Gonads/metabolism , Male , New Brunswick , Testosterone/biosynthesis , Testosterone/blood , Vitellogenins/biosynthesis , Vitellogenins/blood
8.
J Exp Biol ; 206(Pt 3): 543-9, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12502775

ABSTRACT

Lactic acid is produced as an end product of glycolysis in rainbow trout white muscle following exhaustive exercise. The metabolically produced lactic acid causes an intramuscular acidosis that must be cleared, either via net transport out of the muscle or by conversion to glycogen, thereby replenishing the muscle energy store. Trout muscle has been shown to retain lactate and utilise it as a substrate for in situ glycogen resynthesis. The giant sarcolemmal vesicle preparation was used to characterise the potential for lactate loss from white muscle of rainbow trout. Minimal lactate loss was expected due to the requirement within the intramuscular compartment of lactate for glycogen resynthesis. The sarcolemma was found to be highly resistant to lactate loss, with efflux rates approximately 500-fold lower than influx rates [0.049+/-0.006 nmol mg(-1) min(-1) (N=21) versus 26.4+/-6.3 nmol mg(-1) min(-1) (N=5), respectively, at 25 mmol l(-1) lactate concentration]. Lactate efflux was linear over the range 10-250 mmol l(-1) lactate, and greatest under conditions when intravesicular pH was lower than extravesicular pH, but was unaffected by alpha-cyano-4-hydroxycinnamate, a known inhibitor of lactate transport. These results suggest that lactate is relatively impermeant to the trout white muscle membrane and any lactate loss occurs via passive diffusion. This resistance to lactate diffusion can explain why trout muscle retains lactate post-exercise, despite transmembrane gradients that should favour net efflux.


Subject(s)
Lactic Acid/metabolism , Muscle Fibers, Fast-Twitch/physiology , Oncorhynchus mykiss/physiology , Sarcolemma/metabolism , Animals , Biological Transport/drug effects , Diffusion/drug effects , Female , Hydrogen-Ion Concentration , Lactic Acid/pharmacology , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...